{{Rsnum
|rsid=4969168
|Gene=SOCS3
|Chromosome=17
|position=78357712
|Orientation=plus
|GMAF=0.3462
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=SOCS3
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 0.9 | 26.5 | 72.6
| HCB | 21.2 | 48.2 | 30.7
| JPT | 17.7 | 50.4 | 31.9
| YRI | 49.7 | 38.1 | 12.2
| ASW | 35.1 | 43.9 | 21.1
| CHB | 21.2 | 48.2 | 30.7
| CHD | 17.4 | 52.3 | 30.3
| GIH | 6.9 | 28.7 | 64.4
| LWK | 45.5 | 43.6 | 10.9
| MEX | 5.2 | 39.7 | 55.2
| MKK | 23.9 | 51.0 | 25.2
| TSI | 2.0 | 38.2 | 59.8
| HapMapRevision=28
}}{{PMID Auto
|PMID=21892197
|Title=Association of two polymorphisms within and near SOCS3 gene with obesity in three nationalities in Xinjiang province of China
}}

{{PMID|16685656|OA=1
}} Elevated expression and genetic association links the SOCS3 gene to atopic dermatitis.

{{PMID|17881539}} Elevated expression and polymorphisms of SOCS3 influence patient response to antiviral therapy in chronic hepatitis C.

{{PMID|19052638|OA=1
}} Lack of association between the tagging SNP A+930-->G of SOCS3 and type 2 diabetes mellitus: meta-analysis of four independent study populations.

{{PMID|19074178|OA=1
}} Gene expression and hepatitis C virus infection.

{{PMID|19083014|OA=1
}} Polymorphisms near SOCS3 are associated with obesity and glucose homeostasis traits in Hispanic Americans from the Insulin Resistance Atherosclerosis Family Study.

{{PMID Auto
|PMID=23490372
|Title=Association of suppressor of cytokine signalling 3 polymorphisms with insulin resistance in patients with chronic hepatitis C
}}

{{PMID Auto
|PMID=23133602
|Title=Pharmacogenetics of efficacy and safety of HCV treatment in HCV-HIV coinfected patients: significant associations with IL28B and SOCS3 gene variants.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}
{{on chip | NatGeo2}}